REAL-TIME GLOBAL RESEARCH
Are volumes really pivoting?
Research evidence excerpt
Are volumes really pivoting?
Equity Research
European Consumer Staples
31 July 2026
Haleon
HLN is starting to deliver the volume pivot we have been
waiting for. US growth accelerated, EMs strengthened and
margins comfortably beat. With investor jitters around the HLN.L/HLN LN OVERWEIGHT Unchanged
FY25 3-5% OSG guide easing, attention will turn to the European Consumer NEUTRAL
credibility of stepping up to 4-6% OSG in 27. TP to 430p (from Staples Unchanged
415p) OW Price Target GBp 430
raised 4% from GBp 415
Price (30-Jul-26) GBp 369
Haleon’s H1 result was better than the share-price reaction suggests. We think the lack of Potential Upside/Downside +16.7%
a share buyback is a red herring and don't believe there is any real readacross to what Source: Bloomberg, Barclays Research
Haleon may or may not do around acquisitions.Management gave little indication that a
sizeable VMS deal is needed, pointing instead to improving Centrum consumption and Market Cap (GBP mn) 32469
organic innovation opportunities. Leverage was bang on 2.5x EBITDA and we were not Shares Outstanding (mn) 8808.90
expecting a SBB. Free Float (%) 99.97
52 Wk Avg Daily Volume (mn) 15.5Q2 organic growth accelerated to 3.1%, with volume/mix improving from -0.2% in Q1 to +1.4%.
Dividend Yield (%) 1.98North America delivered +2.0% volume/mix and emerging markets grew 6.3%. We would call
Return on Equity TTM (%) 10.04out an important datapoint which is Haleon's ex respiratory growth (due to very weak
Current BVPS (GBp) 185seasonal cold and flu season) accelerated from 3.5% in Q1-26 to 4.7%.
Source: Bloomberg
Margins and cash were also strong. Adjusted gross margin expanded 140bp at constant
currency, adjusted operating profit grew 8.2%, EPS increased 12.0% and free cash flow Price Performance Exchange-LSE
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer